Background: Delayed cerebral ischemia (DCI) is a major cause of morbidity
that too many small, uncontrolled, often retrospective studies provide little definitive guidance on the subject (14) . This lack of clarity has given rise to significant variability in practice amongst US endovascular interventionalists (15 we aim to explore differences in management strategies and suggest possible hypotheses for future study, which could one day lead to a uniform standard of best practice regarding investigation and endovascular therapy for DCI and cerebral vasospasm. Other options that were less commonly volunteered such as glyceryl trinitrate and fasudil hydrochloride were grouped under Other. Responses to questions that specified endovascular therapy that did not include endovascular therapies were excluded. There was significant variation both within and between groups regarding first-line endovascular therapy ( Figure 3A ). Among US practitioners, verapamil was used by 56% of respondents (93/168), while nicardipine, papaverine, milrinone, and nimodipine were used by 25%
(42/168), 7% (12/168), 3% (5/168), and 3% (5/168), respectively. Other firstline therapies chosen by US respondents included fasudil hydrochloride, angioplasty, and angioplasty in combination with pharmaceutical agents.
Among non-US respondents, verapamil was not the most commonly used first-line agent; verapamil was used by only 6% of non-US respondents (9/156). The most common first-line agent chosen by the non-US respondents was nimodipine, which was used by 74% (116/156). Other therapies used by non-US clinicians were nicardipine, milrinone, papaverine, and angioplasty by 3% (5/156), 2% (3/156), 6% (9/156), and 6% (9/156), respectively.
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A total of 80% of respondents (277/344) reported using a second-line endovascular therapy, which also varied between countries. For second-line therapies, larger proportions of respondents opted for angioplasty ( Figure 3B Figure 3B ).
Respondents were also asked to describe the association between their first-line endovascular therapy and immediate angiographic effect as "always," >80%, >50%, <50%, or 10-30%. This was associated with marked variability. However, the reported data suggested that nimodipine was more commonly associated with an immediate angiographic response than was verapamil. 52% (62/117) of responders using nimodipine as a first-line therapy reported an immediate angiographic response always or at least 80% of the time. Only 42% (50/117) of verapamil users, however, reported an immediate response always or at least 80% of the time ( Figure 3C ).
Angioplasty was used by the majority of US and non-US groups, which was reported by 91% (162/177) and 83% (139/167), respectively ( Figure 4A ).
However, 23% of US practitioners (39/168) used angioplasty for distal M A N U S C R I P T
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10 vasospasm compared with 6% (8/139) of non-US respondents ( Figure 4B ), which was a statistically significant difference (p-value < 0.05). In response to the question, "What is the best endovascular therapy for DCI?" the most popular opinion was angioplasty (161/344 of respondents; Figure 4C ). 51%
(90/167) and 61% (107/177) of non-US and US respondents agreed that treatments involving angioplasty offer superior outcomes, which suggests a prevailing view worldwide that angioplasty is the best treatment for DCI
Discussion
We present the results of an international survey of the management of DCI by both US and non-US practitioners. The majority of responders were experienced clinicians with high numbers of SAH cases per year. We found significant variability between the US and the rest of the world in current practice regarding both screening methods and treatment options. We also found significant variability among US respondents in the first-and secondline therapies chosen.
Our results suggest that screening is more commonly used by US clinicians; however, the use is far from ubiquitous, with only 70%, 23%, and 24% of the total sample using daily TCDs, routine CTA, and routine angiography, respectively. Furthermore, some centers inside and outside the US use different techniques such as CTP, the efficacy of which offers an interesting hypothesis for further study. A) <10% B) <50% C) >50% D) >80%
